Cargando…

mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance

Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Meroni, Marica, Longo, Miriam, Erconi, Veronica, Valenti, Luca, Gatti, Stefano, Fracanzani, Anna Ludovica, Dongiovanni, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893471/
https://www.ncbi.nlm.nih.gov/pubmed/31671785
http://dx.doi.org/10.3390/nu11112597
_version_ 1783476206908211200
author Meroni, Marica
Longo, Miriam
Erconi, Veronica
Valenti, Luca
Gatti, Stefano
Fracanzani, Anna Ludovica
Dongiovanni, Paola
author_facet Meroni, Marica
Longo, Miriam
Erconi, Veronica
Valenti, Luca
Gatti, Stefano
Fracanzani, Anna Ludovica
Dongiovanni, Paola
author_sort Meroni, Marica
collection PubMed
description Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factors interact to promote progressive NAFLD during IR. We examined the miRNA signature in insulin receptor haploinsufficient (InsR+/−) and wild-type (wt) HSCs by RNAseq (n = 4 per group). Then, we evaluated their impact in an IR-NASH (nonalcoholic steatohepatitis) model (InsR+/− mice fed standard or methionine choline deficient (MCD) diet, n = 10 per group) and in vitro. InsR+/− HSCs displayed 36 differentially expressed miRNAs (p < 0.05 vs. wt), whose expression was then analyzed in the liver of InsR+/− mice fed an MCD diet. We found that miR-101-3p negatively associated with both InsR+/− genotype and MCD (p < 0.05) and the histological spectrum of liver damage (p < 0.01). miR-101-3p was reduced in InsR+/− hepatocytes and HSCs and even more in InsR+/− cells exposed to insulin (0.33 µM) and fatty acids (0.25 mM), resembling the IR-NASH model. Conversely, insulin induced miR-101-3p expression in wt cells but not in InsR+/− ones (p < 0.05). In conclusion, IR combined with diet-induced liver injury favors miR-101-3p downregulation, which may promote progressive NAFLD through HSC and hepatocyte transdifferentiation and proliferation.
format Online
Article
Text
id pubmed-6893471
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68934712019-12-23 mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance Meroni, Marica Longo, Miriam Erconi, Veronica Valenti, Luca Gatti, Stefano Fracanzani, Anna Ludovica Dongiovanni, Paola Nutrients Article Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factors interact to promote progressive NAFLD during IR. We examined the miRNA signature in insulin receptor haploinsufficient (InsR+/−) and wild-type (wt) HSCs by RNAseq (n = 4 per group). Then, we evaluated their impact in an IR-NASH (nonalcoholic steatohepatitis) model (InsR+/− mice fed standard or methionine choline deficient (MCD) diet, n = 10 per group) and in vitro. InsR+/− HSCs displayed 36 differentially expressed miRNAs (p < 0.05 vs. wt), whose expression was then analyzed in the liver of InsR+/− mice fed an MCD diet. We found that miR-101-3p negatively associated with both InsR+/− genotype and MCD (p < 0.05) and the histological spectrum of liver damage (p < 0.01). miR-101-3p was reduced in InsR+/− hepatocytes and HSCs and even more in InsR+/− cells exposed to insulin (0.33 µM) and fatty acids (0.25 mM), resembling the IR-NASH model. Conversely, insulin induced miR-101-3p expression in wt cells but not in InsR+/− ones (p < 0.05). In conclusion, IR combined with diet-induced liver injury favors miR-101-3p downregulation, which may promote progressive NAFLD through HSC and hepatocyte transdifferentiation and proliferation. MDPI 2019-10-29 /pmc/articles/PMC6893471/ /pubmed/31671785 http://dx.doi.org/10.3390/nu11112597 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Meroni, Marica
Longo, Miriam
Erconi, Veronica
Valenti, Luca
Gatti, Stefano
Fracanzani, Anna Ludovica
Dongiovanni, Paola
mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title_full mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title_fullStr mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title_full_unstemmed mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title_short mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
title_sort mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893471/
https://www.ncbi.nlm.nih.gov/pubmed/31671785
http://dx.doi.org/10.3390/nu11112597
work_keys_str_mv AT meronimarica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT longomiriam mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT erconiveronica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT valentiluca mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT gattistefano mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT fracanzaniannaludovica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance
AT dongiovannipaola mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance